Cadence Bank Na Gsk PLC Transaction History

Cadence Bank Na

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 22, 2021	BUY	$38.79 - $43.16 $3,025 - $3,366	78 Added 0.77%	10,222 $391,000
Q1 2021 May 05, 2021	BUY	$34.27 - $40.01 $3,427 - $4,001	100 Added 1.0%	10,144 $362,000
Q4 2020 Feb 09, 2021	SELL	$34.07 - $39.94 $403,899 - $473,488	-11,855 Reduced 54.13%	10,044 $370,000
Q3 2020 Oct 23, 2020	BUY	$38.11 - $42.99 $51,105 - $57,649	1,341 Added 6.52%	21,899 $824,000
Q2 2020 Jul 31, 2020	BUY	$37.87 - $43.58 $30,636 - $35,256	809 Added 4.1%	20,558 $839,000
Q1 2020 May 11, 2020	BUY	$32.47 - $48.83 $236,219 - $355,238	7,275 Added 58.32%	19,749 $748,000
Q4 2019 Feb 13, 2020	BUY	$42.0 - $48.25 $110,838 - $127,331	2,639 Added 26.83%	12,474 $586,000
Q3 2019 Nov 12, 2019	BUY	$40.46 - $43.52 $7,849 - $8,442	194 Added 2.01%	9,835 $420,000
Q2 2019 Aug 06, 2019	BUY	$39.4 - $42.7 $1,024 - $1,110	26 Added 0.27%	9,641 $386,000
Q1 2019 May 09, 2019	SELL	$38.57 - $42.69 $5,631 - $6,232	-146 Reduced 1.5%	9,615 $401,000
Q4 2018 Feb 08, 2019	BUY	$37.8 - $42.69 $368,965 - $416,697	9,761 New	9,761 $373,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cadence Bank Na, based on Form 13F filings with the SEC.

Stay updated on Cadence Bank Na with notifications on news.